Finasteride, prostate cancer, and weight gain: Evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment

Finasteride affects both prostate cancer risk and body weight. We examined whether, during 7 years of finasteride treatment, the magnitude of weight change was associated with the diagnosis of no, low‐, or high‐grade cancer.

[1]  M. Kattan,et al.  Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. , 2007, Journal of the National Cancer Institute.

[2]  I. Thompson,et al.  Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. , 2007, The Journal of urology.

[3]  I. Thompson,et al.  Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial , 2006, Cancer Epidemiology Biomarkers & Prevention.

[4]  I. Thompson,et al.  Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. , 2006, Journal of the National Cancer Institute.

[5]  S. Cummings,et al.  Testosterone and estradiol among older men. , 2006, The Journal of clinical endocrinology and metabolism.

[6]  N. Makridakis,et al.  Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. , 2005, Journal of molecular endocrinology.

[7]  R. Kim,et al.  Genetic variability in CYP3A5 and its possible consequences. , 2004, Pharmacogenomics.

[8]  A. Weston,et al.  CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review. , 2004, American journal of epidemiology.

[9]  M. Brandi,et al.  A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. , 2004, The Journal of clinical endocrinology and metabolism.

[10]  C. Roehrborn,et al.  Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. , 2010, Urology.

[11]  Michael M Lieber,et al.  The influence of finasteride on the development of prostate cancer. , 2003, The New England journal of medicine.

[12]  P. Scardino,et al.  The prevention of prostate cancer--the dilemma continues. , 2003, The New England journal of medicine.

[13]  J. Crowley,et al.  Chemoprevention of prostate cancer: The prostate cancer prevention trial , 1997, The Prostate.